FDA works with US health insurers to identify drug problems
AUTOR(ES)
Tanne, Janice Hopkins
FONTE
BMJ Publishing Group Ltd.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2335212Documentos Relacionados
- US Medicare reform: why drug companies and private insurers are smiling
- US Institute of Medicine recommends new body to assess what works in health care
- US government agency to investigate FDA over rofecoxib
- FDA to review “missing” drug company documents
- FDA needs more sophisticated approach to drug safety